Modification of cholinergically induced convulsive activity and cyclic GMP levels in the CNS.
D000110:Acetylcholinesterase; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002490:Central Nervous System / Q000378:metabolism*; D002531:Cerebellum / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000633:toxicity*; D002998:Clonazepam / Q000494:pharmacology; D006152:Cyclic GMP / Q000378:metabolism*; D003995:Dibutyryl Cyclic GMP / Q000633:toxicity; D007928:Lethal Dose 50; D008297:Male; D009943:Organophosphorus Compounds / Q000633:toxicity*; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism*; D012999:Soman / Q000633:toxicity*
D000927:Anticonvulsants; D002800:Cholinesterase Inhibitors; D009943:Organophosphorus Compounds; D003995:Dibutyryl Cyclic GMP; D002998:Clonazepam; D012999:Soman; D000110:Acetylcholinesterase; D006152:Cyclic GMP